Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
essanews.com on MSN4d
mRNA vaccine shows promise in tackling pancreatic cancerClinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 clinical trial results reveal an immune response ...
A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.
Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...
Development of an optimized Smart mRNA that specifically detects PDAC (Pancreatic Cancer ... “Current therapies like personalized cancer vaccines have fundamental limitations with the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback